These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 11569941

  • 1. CLX-0901 (Calyx Therapeutics).
    Barlocco D.
    Curr Opin Investig Drugs; 2001 May; 2(5):650-3. PubMed ID: 11569941
    [Abstract] [Full Text] [Related]

  • 2. Insulin detemir. Novo Nordisk.
    Barlocco D.
    Curr Opin Investig Drugs; 2003 Apr; 4(4):449-54. PubMed ID: 12808886
    [Abstract] [Full Text] [Related]

  • 3. Exenatide. Amylin/Eli Lilly.
    Giannoukakis N.
    Curr Opin Investig Drugs; 2003 Apr; 4(4):459-65. PubMed ID: 12808888
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MK-767. Kyorin/Banyu/Merck.
    Calkin AC, Thomas MC, Cooper ME.
    Curr Opin Investig Drugs; 2003 Apr; 4(4):444-8. PubMed ID: 12808885
    [Abstract] [Full Text] [Related]

  • 7. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ, Weiland F.
    Pharm Unserer Zeit; 2002 Apr; 31(3):280-92. PubMed ID: 12071125
    [No Abstract] [Full Text] [Related]

  • 8. Managlinat dialanetil, a fructose-1,6-bisphosphatase inhibitor for the treatment of type 2 diabetes.
    Wang Y, Tomlinson B.
    Curr Opin Investig Drugs; 2007 Oct; 8(10):849-58. PubMed ID: 17907062
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. SomatoKine. Insmed.
    Norman P.
    Curr Opin Investig Drugs; 2003 Apr; 4(4):466-71. PubMed ID: 12808889
    [Abstract] [Full Text] [Related]

  • 11. Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
    Gallwitz B.
    IDrugs; 2008 Dec; 11(12):906-17. PubMed ID: 19051153
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
    Herman GA, Stein PP, Thornberry NA, Wagner JA.
    Clin Pharmacol Ther; 2007 May; 81(5):761-7. PubMed ID: 17392725
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. INT-131, a PPARgamma agonist for the treatment of type 2 diabetes.
    Kintscher U, Goebel M.
    Curr Opin Investig Drugs; 2009 Apr; 10(4):381-7. PubMed ID: 19337960
    [Abstract] [Full Text] [Related]

  • 16. Mitiglinide: a novel agent for the treatment of type 2 diabetes mellitus.
    Phillippe HM, Wargo KA.
    Ann Pharmacother; 2010 Oct; 44(10):1615-23. PubMed ID: 20841518
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes.
    Schimke K, Davis TM.
    Curr Opin Investig Drugs; 2007 Apr; 8(4):338-44. PubMed ID: 17458185
    [Abstract] [Full Text] [Related]

  • 20. Drug evaluation: tagatose in the treatment of type 2 diabetes and obesity.
    Moore MC.
    Curr Opin Investig Drugs; 2006 Oct; 7(10):924-35. PubMed ID: 17086938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.